University of Genoa-ko ikertzaileekin lankidetzan egindako argitalpenak (137)

2024

  1. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients

    The Lancet Infectious Diseases, Vol. 24, Núm. 1, pp. e59-e68

  2. Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

    Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97

  3. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Intensive Care Medicine

  4. Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

    Mycoses, Vol. 67, Núm. 1

  5. The efficacy of telavancin in comparison with linezolid on endotracheal tube biofilm in pigs with methicillin-resistant Staphylococcus aureus pneumonia

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial

    The Lancet Oncology, Vol. 24, Núm. 1, pp. 77-90

  3. Author Correction: Optical coherence tomography in coronary atherosclerosis assessment and intervention (Nature Reviews Cardiology, (2022), 19, 10, (684-703), 10.1038/s41569-022-00687-9)

    Nature Reviews Cardiology

  4. Correction to: Improving clinical paediatric research and learning from COVID-19: recommendations by the Conect4Children expert advice group (Pediatric Research, (2022), 91, 5, (1069-1077), 10.1038/s41390-021-01587-3)

    Pediatric Research

  5. Impact of acute and persistent stent malapposition after percutaneous coronary intervention on adverse cardiovascular outcomes

    Minerva cardiology and angiology, Vol. 71, Núm. 5, pp. 525-534

  6. Management of inflammation in dry eye disease: Recommendations from a European panel of experts

    European Journal of Ophthalmology, Vol. 33, Núm. 3, pp. 1294-1307

  7. Ocular surface in posterior segment surgery

    European Journal of Ophthalmology

  8. Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG

    Critical Care, Vol. 27, Núm. 1

  9. Spatial predictors of immunotherapy response in triple-negative breast cancer

    Nature, Vol. 621, Núm. 7980, pp. 868-876

2022

  1. Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry

    Journal of Rheumatology, Vol. 49, Núm. 4, pp. 398-407

  2. Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review

    Mycoses, Vol. 65, Núm. 3, pp. 362-373

  3. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

  4. Improving clinical paediatric research and learning from COVID-19: recommendations by the Conect4Children expert advice group

    Pediatric Research, Vol. 91, Núm. 5, pp. 1069-1077

  5. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268

  6. Partial Hydrolyzed Protein as a Protein Source for Infant Feeding: Do or Don’t?

    Nutrients, Vol. 14, Núm. 9